Artiva Biotherapeutics

View the org chart displaying its 17 main executives

Most searched biographies at Artiva Biotherapeutics

• Fred Aslan, Director, President and Chief Executive Officer
• Brian Daniels, Chairman of the Board
• Yvonne Yamanaka, Director

Create your alert
to follow the executive moves at Artiva Biotherapeutics.

Artiva Biotherapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Artiva Biotherapeutics

• Artiva NK Cell Therapy News
• Press Releases

Social media about Artiva Biotherapeutics

• Artiva Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Artiva Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Fred Aslan

Call Artiva Biotherapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error